Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Ding YongbiaoCFO |  UMEWUMeWorld Inc.Open-market sale | SELL | $9,000 10.0K sh | Jul 6, 2026 traded Jul 6, 2026 |
| 19 | Robinson Mark HaymondGeneral Counsel and Secretary |  GMEGameStop Corp.Open-market sale · 10b5-1 plan | SELL | $159K 7,083 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 17 | Stojanovic DanijelaInterim CFO |  GEMIGemini Space Station, Inc.Open-market sale | SELL | $37K 8,438 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 17 | Johnson Nancy JoAnnSee Remarks | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $100K 801 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 16 | Renfroe Sean GGENERAL COUNSEL |  TXRHTexas Roadhouse, Inc.Open-market sale · 10b5-1 plan | SELL | $82K 426 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 15 | Graff Marc D.SVP & Chief Financial Officer |  CIENCIENA CORPOpen-market sale · 10b5-1 plan | SELL | $59K 126 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Hancock MarkDirector, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $274K 6,080 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $710K 2,600 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Lewis Michelle ReneeChief Accounting Officer | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $189K 4,200 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 14 | Ford Russell WayneDirector, Chief Executive Officer |  SAROStandardAero, Inc.Open-market sale · 10b5-1 plan | SELL | $1.21M 40.0K sh | Jul 6, 2026 traded Jul 2, 2026 |
| 14 | Sehmi HarminderChief Financial Officer |  BZAIBlaize Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $56K 40.6K sh | Jul 6, 2026 traded Jul 1, 2026 |
| 13 | Roth James MChief Revenue Officer | GTMZoomInfo Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $62K 20.8K sh | Jul 6, 2026 traded Jul 2, 2026 |
| 12 | Lewis Michelle ReneeChief Accounting Officer | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $300K 6,663 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 12 | Lin MarkEVP and CFO |  SMTCSEMTECH CORPOpen-market sale · 10b5-1 plan | SELL | $146K 970 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 12 | Hancock MarkDirector, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $6.44M 142.2K sh | Jul 6, 2026 traded Jul 6, 2026 |
| 12 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $82K 300 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 10 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $284K 900 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 10 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $349K 1,119 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 10 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $338K 1,081 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 10 | Clark KyleDirector, SEE REMARKS |  BETABETA Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $261K 15.0K sh | Jul 6, 2026 traded Jul 1, 2026 |
| 9 | Hancock MarkDirector, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $577K 12.8K sh | Jul 6, 2026 traded Jul 2, 2026 |
| 9 | Lewis Michelle ReneeChief Accounting Officer | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $186K 4,137 sh | Jul 6, 2026 traded Jul 6, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 100 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 9 | Robinson Mark HaymondGeneral Counsel and Secretary | GMEGameStop Corp. Open-market sale · 10b5-1 plan | SELL | $90K 3,957 sh | Jul 6, 2026 traded Jul 6, 2026 |
| 8 | Beatty Jonathan SMD, Head of Advisor Services |  SCHWSCHWAB CHARLES CORPOpen-market sale · 10b5-1 plan | SELL | $200K 2,000 sh | Jul 6, 2026 traded Jul 6, 2026 |
| 8 | Johnston James DavidExecutive VP, GC, CCO and Secy |  SMCSummit Midstream CorpOpen-market sale · 10b5-1 plan | SELL | $77K 2,600 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 8 | Kerdman AlinaSVP, Controller & CAO | CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP Open-market sale · 10b5-1 plan | SELL | $5,455 137 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 8 | Marion Josh R.SVP and General Counsel |  KOSKosmos Energy Ltd.Open-market sale · 10b5-1 plan | SELL | $51K 25.0K sh | Jul 6, 2026 traded Jul 2, 2026 |
| 8 | Beatty Jonathan SMD, Head of Advisor Services | SCHWSCHWAB CHARLES CORP Open-market sale · 10b5-1 plan | SELL | $194K 2,000 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 7 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $219K 700 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 7 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $122K 396 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 7 | Lentz DanielCFO & COO |  CMRCCommerce.com, Inc.Open-market sale · 10b5-1 plan | SELL | $4,570 1,544 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 7 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $190K 600 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 4 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $31K 100 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 4 | Clark KyleDirector, SEE REMARKS | BETABETA Technologies, Inc. Open-market sale · 10b5-1 plan | SELL | $269K 15.0K sh | Jul 6, 2026 traded Jul 2, 2026 |
| 4 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $32K 104 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 3 | Dutt SubirChief Sales Officer |  XMTRXometry, Inc.Open-market sale · 10b5-1 plan | SELL | $19K 199 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $39K 425 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $9,391 99 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $49K 529 sh | Jul 6, 2026 traded Jul 2, 2026 |